Patent: 10,058,480
✉ Email this page to a colleague
Summary for Patent: 10,058,480
| Title: | Device container |
| Abstract: | Device containers, such as therapeutic kit containers, are disclosed. In one embodiment, a device container includes a first member configured to releasably hold a syringe barrel, a second member configured to releasably hold a vial, wherein the second member is coupled to the first member by a first hinge, and a third member configured to releasably hold a vial adapter, wherein the third member is coupled to the second member by a second hinge. |
| Inventor(s): | Christine P. Janson, Ethan B. Jacoby, Frederick Carel Steinmann, Nikhil Gandhi, Chad Presher |
| Assignee: | Bioverativ Therapeutics Inc |
| Application Number: | US14/411,739 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,058,480
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Bioverativ Therapeutics, Inc. | ALPROLIX | coagulation factor ix (recombinant), fc fusion protein | For Injection | 125444 | March 28, 2014 | ⤷ Start Trial | 2033-07-03 |
| Bioverativ Therapeutics, Inc. | ALPROLIX | coagulation factor ix (recombinant), fc fusion protein | For Injection | 125444 | February 18, 2016 | ⤷ Start Trial | 2033-07-03 |
| Bioverativ Therapeutics, Inc. | ALPROLIX | coagulation factor ix (recombinant), fc fusion protein | For Injection | 125444 | July 14, 2016 | ⤷ Start Trial | 2033-07-03 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,058,480
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Argentina | 091670 | ⤷ Start Trial |
| Australia | 2013286673 | ⤷ Start Trial |
| Brazil | 112015000025 | ⤷ Start Trial |
| Canada | 2877972 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
